非肿瘤患者膝关节置换使用大块假体后的患者报告结局与活动度:一项系统综述
本系统综述纳入30项研究(共1294个大块假体),评估非肿瘤适应症患者膝关节大块假体置换后的活动度、功能、疼痛和生活质量。多数研究报告了功能、疼痛、活动度和生活质量的改善,但研究间异质性大且多数存在高偏倚风险,作者认为需要未来比较研究。
要点
- 30项研究中27项存在高偏倚风险,仅3项低偏倚风险。
- 报告基线与随访数据的研究中,功能改善占85.7%(12/14),疼痛改善占100.0%(4/4)。
- 活动度改善占90.9%(10/11),生活质量改善占66.6%(2/3)。
核心结论
- 非肿瘤患者膝关节大块假体置换后观察到良好的功能、疼痛、活动度和生活质量结局。
- 结局指标和随访时间的异质性妨碍了数据合并。
- 作者认为需要未来比较研究来增强非肿瘤患者膝关节大块假体的证据体。
研究设计与样本
- 系统综述,检索MEDLINE、Embase、Cochrane(通过Ovid)和PubMed从2003年1月至2023年6月。
- 纳入报告非肿瘤患者膝关节大块假体功能、疼痛、活动度和/或生活质量的研究,排除样本量n≤5的研究。
- 共纳入30项研究,涉及1294个大块假体;平均随访时间40.1个月(范围1.0至93.5个月)。
- 使用Downs and Black医疗保健干预研究质量清单评估偏倚风险。
主要发现
- 30项研究中,14项为混合适应症,14项仅骨折,1项为股骨远端骨不连,1项为假体周围感染。
- 报告基线与随访功能数据的研究中,85.7%(12/14)显示较术前基线改善。
- 报告基线与随访疼痛数据的研究中,100.0%(4/4)显示改善。
- 报告基线与随访活动度数据的研究中,90.9%(10/11)显示改善。
- 报告基线与随访生活质量数据的研究中,66.6%(2/3)显示改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 27/30项研究存在高偏倚风险。
- 结局指标和随访时间的异质性妨碍了数据合并。
- 作者认为需要未来比较研究来增强非肿瘤患者膝关节大块假体的证据体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This review aimed to determine outcomes following megaprostheses in non-oncological indications for knee arthroplasty, including range of motion (ROM) and patient-reported outcome measures of function, pain, and quality of life (QoL). METHODS: A search of MEDLINE, Embase, and Cochrane via Ovid and PubMed between January 2003 and June 2023 was conducted. Studies reporting function, pain, ROM, and/or QoL in non-oncological patients who have received knee megaprostheses were included. Studies with sample sizes (n ≤ 5) were excluded. The risk of bias was assessed using the Downs and Black Quality Checklist for Health Care Intervention Studies. Central tendency measures (mean or median) were reported at each time point, and dispersion measures were extracted and reported whenever data were available. RESULTS: A total of 30 studies (involving 1,294 megaprostheses) were included. Of which, 14 of 30 studies reviewed patients who had mixed indications; 14 of 30 looked at fracture only; 1 of 30 focused on distal femur nonunion; and 1 of 30 focused on patients who had periprosthetic infections. The average patient follow-up time was 40.1 months (range, 1.0 to 93.5). Most studies presented a high risk of bias (27 of 30), while a few (3 of 30) presented a low risk of bias. Improvements from preoperative baseline were observed in 85.7% of studies that reported baseline and follow-up data for function (12 of 14), 100.0% pain (4 of 4), 90.9% ROM (10 of 11), and 66.6% QoL (2 of 3). CONCLUSIONS: Favorable function, pain, ROM, and QoL outcomes following knee megaprostheses in non-oncological patients were observed. Heterogeneity in outcome measures and follow-up periods prevented the pooling of data. Future comparative studies are warranted to enhance the body of evidence relating to knee megaprostheses in non-oncological patients.
引用
- Crebert MJ, Kasunic D, Karunaratne SR, et al. Patient-Reported Outcomes and Range of Motion Following Knee Arthroplasty Using a Megaprosthesis in Non-Oncological Patients: A Systematic Review. J Arthroplasty. 2024. PMID: 38754706. doi:10.1016/j.arth.2024.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。